🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00268905
Treatments Being Tested
HER2-targeted therapy after the failure of trastuzumab treatment has become...
Status
Unknown
Location
Sun Yat Sen Memorial Hospital，Sun Yat sen University
Start Date
2020-09-09
Trial ID
NCT04681911
Treatments Being Tested
This is a phase II, multicenter, open-label, randomized controlled trial to...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-10-01
Trial ID
NCT06102824
The researchers are doing this study to find out if the study drug, enzalut...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-10-18
Trial ID
NCT06099769
Treatments Being Tested
A Single-Center Retrospective Study About Efficacy and Safety of Eribulin-B...
Status
Unknown
Location
Fujian Cancer Hospital
Start Date
2023-02-01
Trial ID
NCT05953909
Treatments Being Tested
This study will evaluate the safety and efficacy of eribulin in combination...
Status
Terminated
Location
Holy Cross Hospital
Start Date
2011-08
Trial ID
NCT01388647
Treatments Being Tested
The study is being conducted to evaluate VEGFR BP102 with nab-paclitaxe or ...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2023-04-25
Trial ID
NCT05806060
Treatments Being Tested